EQT Life Sciences has held the final close of its inaugural LSP Dementia Fund raising approximately EUR 260 million in fee-generating assets under management, meeting the hard cap and surpassing the target fund size of EUR 100 million.

The fund is dedicated to investing in companies that are developing breakthrough drug therapies and medical technologies